Systematic Review and Meta-analysis of Real-World Adherence to Drug Therapy for Osteoporosis

Kothawala, Prajesh; Badamgarav, Enkhe; Seonyoung Ryu; Miller, Ross M.; Halbert, R. J.
December 2007
Mayo Clinic Proceedings;Dec2007, Vol. 82 Issue 12, p1493
Academic Journal
OBJECTIVE: To quantify the adherence of patients to drug therapy for osteoporosis in real-world settings via a systematic review and meta-analysis of observational studies. METHODS: The PubMed and Cochrane databases were searched for English-language observational studies published from January 1, 1990, to February 15, 2006, that assessed patient adherence to drug therapy for osteoporosis using the following medical subject headings and keywords: drug therapy, medication adherence, medication persistence, medication possession ratio, patient compliance, and osteoporosis. Studies were stratified into 3 groups: persistence (how long a patient continues therapy), compliance (how correctly, in terms of dose and frequency, a patient takes the medication), and adherence (a combination of persistence and compliance). A random-effects model was used to pool results from the selected studies. RESULTS: Twenty-four studies were included in the meta-analysis. The pooled database-derived persistence rate was 52% (95% confidence interval [Cl], 44%-59%) for treatment lasting 1 to 6 months, 50% (95% Cl, 37%-63%) for treatment lasting 7 to 12 months, 42% (95% Cl, 20%-68%) for treatment lasting 13 to 24 months, returning to 52% (95% Cl, 45%-58%) for treatment lasting more than 24 months. Pooled adherence rates decreased from 53% (95% Cl, 52%-54%) for treatment lasting 1 to 6 months to 43% for treatment lasting 7 to 12 months (95% Cl, 38%-49%) or 13 to 24 months (43%; 95% Cl, 32%-54%). The pooled refill compliance estimate was 68% (95% Cl, 63%-72%) for treatment lasting 7 to 12 months and 68% (95% Cl, 67%-69%) for treatment lasting 13 to 24 months. The pooled self-reported compliance rate was 62% (95% Cl, 48%-75%) for treatment lasting 1 to 6 months and 66% (95% Cl, 45%-81%) for treatment lasting 7 to 12 months. CONCLUSION: One-third to half of patients do not take their medication as directed. Nonadherence occurs shortly after treatment initiation. Terms and definitions need to be standardized to permit comparability of technologies designed to improve patient adherence. Prospective trials are needed to assess the relationship between adherence and patient outcomes.


Related Articles

  • COMMENTARY: Review: Good adherence (compared with poor adherence) to drug therapy is associated with a reduction in mortality. Avorn, Jerry // ACP Journal Club;Nov/Dec2006, Vol. 145 Issue 3, p80 

    The article presents the author's views on a study that was conducted to examine how good adherence to drug therapy is linked to a reduction in mortality. It was reported that patients' use of medications over time found similarly reduced mortality rates in good compared with poor compliers,...

  • Review: Good adherence (compared with poor adherence) to drug therapy is associated with a reduction in mortality.  // ACP Journal Club;Nov/Dec2006, Vol. 145 Issue 3, p80 

    The article presents information on a study that was conducted to examine how good adherence to drug therapy is associated with a reduction in mortality. Meta-analysis showed that fewer patients with good adherence died than did those with poor adherence; similar results were found when...

  • Fractured fortunes. Bainbridge, Penny // Nursing Standard;9/14/2005, Vol. 20 Issue 1, p30 

    Focuses on the publication of a survey by the International Osteoporosis Foundation that sought to understand the reasons for adherence of osteoporotic patients to treatment in Great Britain. Estimation of people affected with osteoporosis in the region; Means of reducing the risk of fracture;...

  • Drug packaging can improve compliance, data show. Celia, Frank // Drug Topics;6/7/2004, Vol. 148 Issue 11, p34 

    Though it is generally assumed that enhancements in drug packaging could significantly improve patient compliance, no one has ever confirmed it in a double-blind randomized, clinically controlled study. Philip J. Schneider is hoping to change that, and preliminary data he unveiled at the 2004...

  • From Morisky to Hill-Bone; Self-reports Scales for Measuring Adherence to Medication. Culig, Josip; Leppée, Marcel // Collegium Antropologicum;Mar2014, Vol. 38 Issue 1, p55 

    There are a number of approaches to studying medication-taking behavior. Self-report measures that have the benefits of being cheap, easy to administer, non-intrusive, and able to provide information on attitudes and beliefs about medication. Potential limitations to self-report are that ability...

  • Comparison of recommendations for the use of anti-tumour necrosis factor therapy in ankylosing spondylitis in 23 countries worldwide. van den Berg, Rosaline; Stanislawska-Biernat, Ewa; van der Heijde, Désirée M. F. M. // Rheumatology;Dec2011, Vol. 50 Issue 12, p2270 

    Objective. To give an overview of the recommendations for the use of anti-TNF-α therapy in AS in 23 countries worldwideMethods. The recommendations were collected, translated and a summary was checked by Assessment of SpondyloArthritis International Society (ASAS) members from the respective...

  • There's no simple route to compliance, study finds. Ukens, Carol // Drug Topics;1/20/2003, Vol. 147 Issue 2, p31 

    Discusses results of a research study which concluded that complex compliance programs are not effective in making patient adhere to long-term drug therapy instructions. Components of long-term care; Medical conditions which were studied for adherence.

  • How to Get Patients To Take Their Medicine. Sullivan, Joanne M. // Review of Ophthalmology;Sep2000, Vol. 7 Issue 9, p82 

    Discusses tips on how to get patients to take their medicine. Understanding the barriers to compliance; Factors affecting compliance; Ways to encourage compliance.

  • "Medication readiness" scale assists in determining patients' ability to adhere with medications.  // Formulary;Aug2001, Vol. 36 Issue 8, p613 

    Reports on the development of a medication readiness scale by clinical staff members at the Quincy Mental Health Center in Massachusetts. Aim of identifying ways to reduce patient medication non-adherence; Involvement of representatives from pharmacy, medicine, nursing, occupational therapy,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics